Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TEMANOGREL
(2)
Small molecule
Serotonin 2a (5-HT2a) receptor inverse agonist
Unknown
Investigational
Unknown
TEMANOGREL
×
Maximum Phase:
2
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
VALILOXYBATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALILOXYBATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLSAMIDORPHAN
(2)
Small molecule
Mu opioid receptor antagonist
Unknown
Investigational
Unknown
METHYLSAMIDORPHAN
×
Maximum Phase:
2
First Approval:
None
UNII:
8347HC35J6
Molecule Type:
Small molecule
Molecular Formula:
C22H29N2O4+
Molecular Weight:
385.48
AlogP:
1.4
PSA:
100.62
HBD:
3.0
HBA:
#RotB:
3.0
Source:
OLODANRIGAN
(2)
Small molecule
Angiotensin II type 2 (AT-2) receptor antagonist
Unknown
Investigational
Unknown
OLODANRIGAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0FN522VTO
Molecule Type:
Small molecule
Molecular Formula:
C32H29NO5
Molecular Weight:
507.59
AlogP:
5.44
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SRX246
(2)
Small molecule
Vasopressin V1a receptor antagonist
Unknown
Investigational
Unknown
SRX246
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C43H48F3N5O5
Molecular Weight:
771.88
AlogP:
6.6
PSA:
102.5
HBD:
1.0
HBA:
#RotB:
11.0
Source:
TETRAHYDROCANNABIVARIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TETRAHYDROCANNABIVARIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I5YE3I47D8
Molecule Type:
Small molecule
Molecular Formula:
C19H26O2
Molecular Weight:
286.42
AlogP:
4.96
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MB07811
(2)
Small molecule
Thyroid hormone receptor beta-1 agonist
Unknown
Investigational
Unknown
MB07811
×
Maximum Phase:
2
First Approval:
None
UNII:
3Z11398FNQ
Molecule Type:
Small molecule
Molecular Formula:
C28H32ClO5P
Molecular Weight:
514.99
AlogP:
8.08
PSA:
64.99
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CANNABIDIOL ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CANNABIDIOL ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
FJX8O3OJCD
Molecule Type:
Small molecule
Molecular Formula:
C22H30O4
Molecular Weight:
358.48
AlogP:
5.54
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DAROTROPIUM BROMIDE
(2)
Small molecule
Muscarinic acetylcholine receptor antagonist
Unknown
Investigational
Unknown
DAROTROPIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2W2V1U785A
Molecule Type:
Small molecule
Molecular Formula:
C24H29BrN2
Molecular Weight:
425.41
AlogP:
4.9
PSA:
23.79
HBD:
0.0
HBA:
#RotB:
4.0
Source:
IDREVLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IDREVLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENOXOLONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ENOXOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
P540XA09DR
Molecule Type:
Small molecule
Molecular Formula:
C30H46O4
Molecular Weight:
470.69
AlogP:
6.41
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TRANIMILAST
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRANIMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COSITECAN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
COSITECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
24R60NVC41
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O4Si
Molecular Weight:
448.6
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DINALBUPHINE SEBACATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DINALBUPHINE SEBACATE
×
Maximum Phase:
2
First Approval:
None
UNII:
464OXX39Y6
Molecule Type:
Small molecule
Molecular Formula:
C52H68N2O10
Molecular Weight:
881.12
AlogP:
5.95
PSA:
158.46
HBD:
4.0
HBA:
#RotB:
15.0
Source:
ND0801
(2)
Small molecule
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
Unknown
Investigational
Unknown
ND0801
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLESATINIB
(2)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Investigational
Unknown
GLESATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
7Q29OXD98N
Molecule Type:
Small molecule
Molecular Formula:
C31H27F2N5O3S2
Molecular Weight:
619.72
AlogP:
6.22
PSA:
97.4
HBD:
3.0
HBA:
#RotB:
11.0
Source:
MILVETEROL
(2)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Investigational
Unknown
MILVETEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
LGY1VQ9622
Molecule Type:
Small molecule
Molecular Formula:
C25H29N3O4
Molecular Weight:
435.52
AlogP:
2.97
PSA:
113.85
HBD:
6.0
HBA:
#RotB:
12.0
Source:
EMICERFONT
(2)
Small molecule
Corticotropin releasing factor receptor 1 antagonist
Unknown
Investigational
Unknown
EMICERFONT
×
Maximum Phase:
2
First Approval:
None
UNII:
OJ8EG4264P
Molecule Type:
Small molecule
Molecular Formula:
C22H24N6O2
Molecular Weight:
404.47
AlogP:
3.12
PSA:
75.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SODIUM NITRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SODIUM NITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8M4L3H2ZVZ
Molecule Type:
Small molecule
Molecular Formula:
NNaO3
Molecular Weight:
84.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ISUZINAXIB HYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ISUZINAXIB HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q99G5ZE5U5
Molecule Type:
Small molecule
Molecular Formula:
C17H18ClN3O
Molecular Weight:
315.8
AlogP:
3.59
PSA:
50.94
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LANICEMINE
(2)
Small molecule
Glutamate [NMDA] receptor blocker
Unknown
Investigational
Unknown
LANICEMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9TMU325RK3
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2
Molecular Weight:
198.27
AlogP:
2.32
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
HT-0712
(2)
Small molecule
Phosphodiesterase 4 inhibitor
Unknown
Investigational
Unknown
HT-0712
×
Maximum Phase:
2
First Approval:
None
UNII:
2O43FXG9IG
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO3
Molecular Weight:
393.53
AlogP:
4.79
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OBI-3424
(2)
Small molecule
DNA cross-linking agent
Unknown
Investigational
Unknown
OBI-3424
×
Maximum Phase:
2
First Approval:
None
UNII:
X6SH5T8H76
Molecule Type:
Small molecule
Molecular Formula:
C21H25N4O6P
Molecular Weight:
460.43
AlogP:
3.91
PSA:
105.0
HBD:
0.0
HBA:
#RotB:
9.0
Source:
RADAFAXINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RADAFAXINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q47741214K
Molecule Type:
Small molecule
Molecular Formula:
C13H18ClNO2
Molecular Weight:
255.74
AlogP:
2.27
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PIDOLIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PIDOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
SZB83O1W42
Molecule Type:
Small molecule
Molecular Formula:
C5H7NO3
Molecular Weight:
129.12
AlogP:
-0.65
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SRT-2104
(2)
Small molecule
NAD-dependent deacetylase sirtuin 1 activator
Unknown
Investigational
Unknown
SRT-2104
×
Maximum Phase:
2
First Approval:
None
UNII:
4521NR0J09
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O2S2
Molecular Weight:
516.65
AlogP:
4.97
PSA:
84.65
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BUDIODARONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BUDIODARONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5Y53150C8
Molecule Type:
Small molecule
Molecular Formula:
C27H31I2NO5
Molecular Weight:
703.35
AlogP:
6.48
PSA:
68.98
HBD:
0.0
HBA:
#RotB:
12.0
Source:
13-DEOXYDOXORUBICIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
13-DEOXYDOXORUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
1S9VO1DQG5
Molecule Type:
Small molecule
Molecular Formula:
C27H31NO10
Molecular Weight:
529.54
AlogP:
0.82
PSA:
189.0
HBD:
6.0
HBA:
#RotB:
5.0
Source:
OROTIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
OROTIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
61H4T033E5
Molecule Type:
Small molecule
Molecular Formula:
C5H4N2O4
Molecular Weight:
156.1
AlogP:
-1.24
PSA:
103.02
HBD:
3.0
HBA:
#RotB:
1.0
Source:
TERN-101
(2)
Small molecule
Bile acid receptor FXR agonist
Unknown
Investigational
Unknown
TERN-101
×
Maximum Phase:
2
First Approval:
None
UNII:
VVA2ZDV3LX
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAROVASERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DAROVASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E0YF0M8O09
Molecule Type:
Small molecule
Molecular Formula:
C22H23F3N8O
Molecular Weight:
472.48
AlogP:
3.1
PSA:
135.94
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BMS-813160
(2)
Small molecule
C-C chemokine receptor type 2 antagonist
Unknown
Investigational
Unknown
BMS-813160
×
Maximum Phase:
2
First Approval:
None
UNII:
83U7957287
Molecule Type:
Small molecule
Molecular Formula:
C25H40N8O2
Molecular Weight:
484.65
AlogP:
2.25
PSA:
116.55
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DEOXYCYTIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEOXYCYTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0W860991D6
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O4
Molecular Weight:
227.22
AlogP:
-1.53
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK2798745
(2)
Small molecule
Transient receptor potential cation channel subfamily V member 4 antagonist
Unknown
Investigational
Unknown
GSK2798745
×
Maximum Phase:
2
First Approval:
None
UNII:
63FJ7LF55O
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFP-464
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AFP-464
×
Maximum Phase:
2
First Approval:
None
UNII:
73JNH95XPX
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3N4O9S2
Molecular Weight:
668.71
AlogP:
3.94
PSA:
137.37
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ALDOXORUBICIN HYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALDOXORUBICIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
S098K6HGD9
Molecule Type:
Small molecule
Molecular Formula:
C37H43ClN4O13
Molecular Weight:
787.22
AlogP:
0.39
PSA:
267.84
HBD:
7.0
HBA:
#RotB:
12.0
Source:
1
2
…
149
150
151
152
153
154
155
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA